公司資料
Xencor 股價、新聞與催化劑
- 股票代碼:
- XNCR
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
29.00 USD (+4.30%)
收盤價
最後更新: 2026年8月24日
831M USD
市值
股價為何變動
As of Aug 24, 2026, XNCR closed up 4.30% at $29.00. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Xencor is a biotechnology company built around antibody engineering and next-generation immunology and oncology programs. Its platform approach gives it optionality across multiple therapeutic areas.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Xencor sits in specialty biotechnology.
商業模式特徵
The business blends partnered programs, internal development, and platform science, with valuation tied to data quality and collaboration economics.
生技產業定位
Xencor is a platform antibody name that can re-rate quickly when clinical data or partner progress strengthens confidence in the platform.
未來催化劑
- Xencor's catalysts are XmAb platform updates, including vudalimab and other bispecific programs that can still create partnered or internal value. The company needs data that show the platform keeps producing.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。